KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Gross Margin (2016 - 2025)

Thermo Fisher Scientific's Gross Margin history spans 17 years, with the latest figure at 69.53% for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 205.0% year-over-year to 69.53%, compared with a TTM value of 70.14% through Dec 2025, down 80.0%, and an annual FY2025 reading of 69.91%, down 57.0% over the prior year.
  • Gross Margin for Q4 2025 was 69.53% at Thermo Fisher Scientific, down from 71.05% in the prior quarter.
  • The five-year high for Gross Margin was 137.36% in Q4 2021, with the low at 63.85% in Q3 2021.
  • Average Gross Margin over 5 years is 75.45%, with a median of 70.31% recorded in 2023.
  • Year-over-year, Gross Margin surged 1360bps in 2021 and then tumbled -4724bps in 2022.
  • Tracing TMO's Gross Margin over 5 years: stood at 137.36% in 2021, then plummeted by -34bps to 90.11% in 2022, then dropped by -27bps to 65.71% in 2023, then increased by 9bps to 71.58% in 2024, then fell by -3bps to 69.53% in 2025.
  • Per Business Quant, the three most recent readings for TMO's Gross Margin are 69.53% (Q4 2025), 71.05% (Q3 2025), and 70.16% (Q2 2025).